Current situation and future trend of traditional Chinese medicine innovation developmentWANG Chun-li, LI Zi-yan2013-2021
Analysis of drugs marketed under the U.S.breakthrough therapy designation program and their innovation pointsWANG Ya-xing, GONG Shi-wei2022-2028
Zynteglo,the world's first gene therapy for transfusion-dependent β-thalassemiaCAO Jing, TANG Zhe, SHUAI Wei-wei2029-2033
Phosphodiesterase-4 inhibitor roflumilast for topical treatment of plaque psoriasisWANG Qian-qian, YIN Qi, JIANG Cheng2034-2038
Introduction to the U.S.FDA's"Good Abbreviated New Drug Application Assessment Practices"and reflections thereofWANG Shao-rong, ZHANG Jun-lin, BAI Yu2039-2043
Progress in research on drugs for treatment of nonalcoholic steatohepatitisLIU Yu-yan, ZHU Han-zhi, JIA Bu-yun, CHEN Guang-liang2044-2050
Biodistribution study of expanded activated lymphocytes in severe immunodeficient miceHOU Tian-tian, LI Xue-jiao, JIANG Hua, QIN Chao, YAO Zhi-wei, HUO Yan, GENG Xing-chao, HUANG Ying2051-2057
Progress in study on biological activities and preparation of ergosterol peroxideLIU Peng, LIU Xue-lian, LI Jin-yao2058-2065
Research progress in biopharmaceutics of nanocrystals injectionJIN He-xiang, TU Lu-ping, RAO Ze-peng, LU Jia-yan, WANG Wen-xi2066-2072